Previous work suggested that activation of the ISR is at least partially responsible for the peripheral neuropathy caused by GlyRS mutations (15,16), and mutations in glutamyl-prolyl-tRNA synthetase in diabetic patients also activate ISR (50). Here, GARS1 is linked to peripheral neuropathy.